Trials / Completed
CompletedNCT01798134
Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a non-randomized, prospective, pilot, Multicenter Study of Drug-eluting bead transarterial chemoembolization (DEB-TACE) using Doxorubicin-Loaded Embozene® Tandem™ Microspheres to treat hepatocellular carcinoma (HCC).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TANDEM™ |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2014-11-01
- Completion
- 2015-03-01
- First posted
- 2013-02-25
- Last updated
- 2016-10-03
- Results posted
- 2016-06-27
Locations
7 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01798134. Inclusion in this directory is not an endorsement.